Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for Appetite in Advanced Cancer Patients
NCT00488072Phase 2Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2007
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anorexia nervosa (AN) and Insomnia comparing Mirtazapine with Placebo (2 arms). Primary endpoint: Edmonton Symptom Assessment Scale (ESAS) Appetite Score at Day 28. Started Jan 2007; status: active, not recruiting.
02
Drugs
mirtazapine
03
Conditions
anorexia nervosa (AN)Insomnia
Beyond the preview
Go deeper on NCT00488072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488072.